UK +44 (0)1865 849841
Malaysia +603 2731 9335

Precision Medicine Resources

Welcome to the Precision Medicine resources page: a curated list of presentation videos and slide decks.

These resources were produced from our Precision Medicine series of events. Keep up to date with all of the latest precision medicine news by signing up to our Precision Newsletter

Presentation Videos

Decreasing the Risk of Immunotoxicity for Cancer Immunotherapies: Webinar

Giovanni Mazzocco Senior Scientist, Ardigen; Piotr Skoczylas Data Scientist, Ardigen; Piotr Stępniak Director of Strategy & Alliance, Ardigen

Genomics, big data and the next generation of targeted therapies

Lon Cardon, SVP Alternative Discovery & Development, GSK

Clinical utility for detection and monitoring circulating tumor DNA from urine and plasma

Mark Erlander, CSO, Trovagene

Checkpoint blockade in cancer immunotherapy: delivery on the promise

Akintunde Bello, Executive Director Clinical Pharmacology and Pharmacometrics Oncology and Immuno Oncology, BMS

Towards Precision Medicine in Inflammatory Bowel Disease

Andres Hurtado-Lorenzo, Senior Director – Translational Research, Crohn’s & Colitis Foundation

Presentation Slides

Expanding Precision Medicine and Biomarker Strategy Options with RNAscope

Christopher Bunker, VP Business Development, Advanced Cell Diagnostics, Inc

Success through novel collaborations, value-added services, and early patient involvement

Armin Furtwangler, Global Senior Medical Director – Health Care Innovation, Boehringer Ingelheim Pharma

Precision Medicine in Rheumatology

Thibault Helleputte, Founder & CEO, DNAlytics

Towards Precision Medicine in Inflammatory Bowel Diseases

Andres Hurtado-Lorenzo, Senior Director – Translational Reserch, Crohn’s & Colitis Foundation

Utility of Flow Cytometry Assays in Clinical Trials: A Provider’s Perspective

Nick Jones, Global Flow Lead – Pharma Services, NeoGenomics

Using Synthetic DNA to power Antibody Discovery and Optimisation

Ross Kettleborough, Technical Director, Europe, Twist Bioscience

T4 Pan-ERB-Targeted CAR T-Cell Immunotherapy of Head and Neck Cancer: Phase I Trial Results

John Maher, CSO, Leucid Bio

RNA Biomarker Discovery in Exosomes and Liquid Biopsies by Sequencing and qPCR

Peter Mouritzen, Vice President for Research and Development, Exiqon

Precision Medicine- Growth Opportunities for Genomics Technologies

Nitin Naik, Global Vice President, Life Sciences Transformational Health, Frost & Sullivan

Antibody libraries based on an autonomous human variable domain

Johan Nilvebrant, Researcher, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH

Liquid Biopsies in the Clinic – Development and Validation of a Pan-Cancer Liquid Biopsy Test

Honey Reddi, Clinical Laboratory Director, The Jackson Laboratory

Precision Medicine in a Data Rich Era – Key Challenges and Successful Approaches

Thomas Skot Jensen CEO, Intomics

Will whole genome sequencing of fresh frozen tumour material become the assay of choice for cancer molecular diagnostics?

Will Spooner, Commercial Programme Delivery Lead, Genomics England

Precision Medicine at AstraZeneca: A patient-focused approach

Dr Thorsten S Gutjahr, VP, Global Head of Diagnostics, AstraZeneca, UK

Prepare to explore the tumor micro environment

Martijn Van Baalen, Head Flow Cytometry Facility, Netherlands Cancer Institute

Resource Title

Mona Welschof, Head of Clinical Operation, Zelluna Therapeutics

Chromoplexis and chromothripsis can increase neoantigen load

George Vasmatzis, Co-director of the Biomarker Discovery Program, Associate Professor, Department of Molecular Medicine, Mayo Clinic, USA

Viral-based vaccine for cancer neoantigen vaccination

Astrid Visser, Business Development Manager, Sanquin

Poster Presentations

In vitro HLA peptide-binding assay and HLA tetramer combinatorial coding technique improve selection of candidate CD8+ T cell epitopes for immunotherapy

Wim van Esch, Juk Yee Mok, Giso Brasser, Dionne Geerdes, and Astrid Visser

Development of the First WHO International Standards for ctDNA

VITVO™: A Novel 3D In Vitro System For Functional itro System For Functional Prediction Of Patient Anti-tumor Immune Response to Checkpoint Inhibitors